| 1 | 3 mg [14C]-A4250 capsule | - | - | - | - | 3件: 93 93, 297, 338 💬
|
| 2 | [A4250] | - | - | - | - | 3件: 296 296, 297, 338 💬
|
| 3 | A4250 | - | - | - | - | 4件: 93 93, 296, 297, 338 💬
|
| 4 | A4250-015 | - | - | - | - | 1件: 297 297 💬
|
| 5 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 21件: 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 6 | CRC (A3384) | - | - | - | - | 3件: 93 93, 297, 338 💬
|
| 7 | Livmarli | - | - | - | - | 2件: 297 297, 338 💬
|
| 8 | Livmarli Oral Product | - | - | - | - | 2件: 297 297, 338 💬
|
| 9 | LUM001 | - | - | - | - | 4件: 93 93, 94, 297, 338 💬
|
| 10 | LUM001 (Maralixibat) | 1件: Maralixibat Maralixibat | 2件: Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| 2件: SLC10A1 SLC10A1, SLC10A2 💬
| 3件: Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | 2件: 297 297, 338 💬
|
| 11 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 23件: 3 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
|
| 12 | Magnesium gluconate | 2件: Magnesium Magnesium, Magnesium gluconate | 1件: Magnesium gluconate
Magnesium gluconate
💬
| - | - | 2件: 296 296, 297 💬
|
| 13 | Magnesium sulfate | 2件: Magnesium Magnesium, Magnesium sulfate | 1件: Magnesium sulfate
Magnesium sulfate
💬
| - | - | 4件: 11 11, 97, 296, 297 💬
|
| 14 | Maralixibat | 1件: Maralixibat Maralixibat | 2件: Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| 2件: SLC10A1 SLC10A1, SLC10A2 💬
| 3件: Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | 4件: 296 296, 297, 299, 338 💬
|
| 15 | Maralixibat (formely SHP625 or LUM001) | 1件: Maralixibat Maralixibat | 2件: Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| 2件: SLC10A1 SLC10A1, SLC10A2 💬
| 3件: Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | 3件: 296 296, 297, 338 💬
|
| 16 | Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 5-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 10-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 15-Product Name: Maralixibat (formely SHP625 or LUM001)Pharmaceutical Form: Oral solutionINN or Proposed INN: MARALIXIBAT CHLORIDECAS Number: 228113-66-4Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 20- | 1件: Maralixibat Maralixibat | 2件: Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| 2件: SLC10A1 SLC10A1, SLC10A2 💬
| 3件: Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | 3件: 296 296, 297, 338 💬
|
| 17 | MARALIXIBAT CHLORIDE | 1件: Maralixibat Maralixibat | 2件: Maralixibat
Maralixibat
,
Maralixibat chloride
💬
| 2件: SLC10A1 SLC10A1, SLC10A2 💬
| 3件: Bile secretion Bile secretion, Hepatitis B, Virion - Hepatitis viruses 💬 | 3件: 296 296, 297, 338 💬
|
| 18 | Odevixibat | 1件: Odevixibat Odevixibat | 2件: Odevixibat
Odevixibat
,
Odevixibat hydrate
💬
| 1件: SLC10A2 SLC10A2 💬
| 1件: Bile secretion Bile secretion 💬 | 3件: 296 296, 297, 338 💬
|
| 19 | OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 200-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 400-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 600-Product Name: OdevixibatProduct Code: A4250Pharmaceutical Form: Capsule, hardINN or Proposed INN: OdevixibatCAS Number: 501692-44-0Current Sponsor code: A4250Other descriptive name: A4250Concentration unit: µg microgram(s)Concentration type: equalConcentration number: 1200- | - | - | - | - | 1件: 297 297 💬
|
| 20 | Questran | - | - | - | - | 4件: 93 93, 254, 297, 338 💬
|
| 21 | TAK-625 | - | - | - | - | 2件: 297 297, 338 💬
|